Aurel Constant Allabi

653 total citations
20 papers, 510 citations indexed

About

Aurel Constant Allabi is a scholar working on Pharmacology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aurel Constant Allabi has authored 20 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aurel Constant Allabi's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Aurel Constant Allabi is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Aurel Constant Allabi collaborates with scholars based in Benin, Belgium and Zambia. Aurel Constant Allabi's co-authors include Yves Horsmans, Jean‐Luc Gala, K. A. Busia, Jean‐Pierre Desager, Michel Heusterspreute, Trevor N. Johnson, Lisa M. Almond, Cyrus Ghobadi, Mohsen Aarabi and Amin Rostami‐Hodjegan and has published in prestigious journals such as Journal of Ethnopharmacology, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Aurel Constant Allabi

20 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurel Constant Allabi Benin 9 263 171 99 76 68 20 510
Mary Jande Tanzania 12 331 1.3× 170 1.0× 99 1.0× 52 0.7× 94 1.4× 23 599
Michael Deters Germany 18 142 0.5× 133 0.8× 176 1.8× 184 2.4× 33 0.5× 42 865
C. H. Shashindran India 12 175 0.7× 62 0.4× 44 0.4× 54 0.7× 58 0.9× 24 383
Feng Yu China 17 221 0.8× 59 0.3× 23 0.2× 103 1.4× 68 1.0× 41 781
James B. Mangold United States 15 206 0.8× 167 1.0× 32 0.3× 154 2.0× 121 1.8× 26 645
Hidetoshi Furuie Japan 13 129 0.5× 154 0.9× 75 0.8× 127 1.7× 82 1.2× 32 635
Dorothee Frank Germany 7 254 1.0× 132 0.8× 89 0.9× 41 0.5× 48 0.7× 7 428
A N Nafziger United States 9 339 1.3× 175 1.0× 129 1.3× 291 3.8× 114 1.7× 10 784
Debra S. Israel United States 15 154 0.6× 87 0.5× 72 0.7× 122 1.6× 30 0.4× 20 583
Y Clément Trinidad and Tobago 12 214 0.8× 61 0.4× 19 0.2× 43 0.6× 32 0.5× 30 743

Countries citing papers authored by Aurel Constant Allabi

Since Specialization
Citations

This map shows the geographic impact of Aurel Constant Allabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurel Constant Allabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurel Constant Allabi more than expected).

Fields of papers citing papers by Aurel Constant Allabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurel Constant Allabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurel Constant Allabi. The network helps show where Aurel Constant Allabi may publish in the future.

Co-authorship network of co-authors of Aurel Constant Allabi

This figure shows the co-authorship network connecting the top 25 collaborators of Aurel Constant Allabi. A scholar is included among the top collaborators of Aurel Constant Allabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurel Constant Allabi. Aurel Constant Allabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mudenda, Steward, et al.. (2024). Antibiotic use at the Centre Hospitalier Universitaire de Zone d'Abomey Calavi/Sô-Ava (CHUZ/AS) in Benin: a point prevalence survey. JAC-Antimicrobial Resistance. 7(1). dlae220–dlae220. 4 indexed citations
2.
Allabi, Aurel Constant, et al.. (2023). Antimicrobial Stewardship: Knowledge and Attitudes of Pharmacy Staff on Antibiotic Dispensing Patterns, Use and Resistance in Benin. Pharmacology & Pharmacy. 14(6). 189–214. 9 indexed citations
3.
Allabi, Aurel Constant, et al.. (2023). Nonmedical Use of Prescription Psychotropic Drugs among Secondary School Students in Parakou, northern Benin. 10(1). 1–1. 2 indexed citations
4.
Mudenda, Steward, Billy Chabalenge, Victor Daka, et al.. (2023). Antimicrobial stewardship: knowledge, attitudes and practices regarding antimicrobial use and resistance among non-healthcare students at the University of Zambia. JAC-Antimicrobial Resistance. 5(6). dlad116–dlad116. 16 indexed citations
5.
6.
Damien, Georgia, et al.. (2022). Prevalence, associated factors and level of dependence of substance use among urban secondary school students, Benin. Basic & Clinical Pharmacology & Toxicology. 131(3). 205–213. 5 indexed citations
7.
Damien, Georgia, et al.. (2021). Nonmedical use of tramadol among secondary school students in Benin, Africa. The American Journal of Drug and Alcohol Abuse. 47(6). 746–752. 6 indexed citations
8.
Allabi, Aurel Constant, et al.. (2020). A Phase II Pilot Trial to Evaluate CoBaT-Y017 Safety and Efficacy against Uncomplicated Falciparum Malaria versus Artemether‐Lumefantrine in Benin Subjects. Evidence-based Complementary and Alternative Medicine. 2020(1). 8715021–8715021. 1 indexed citations
9.
Allabi, Aurel Constant, et al.. (2019). Short-Term Safety and Tolerability of an Antimalarial Herbal Medicine, CoBaT-Y017 in Healthy Volunteers. Evidence-based Complementary and Alternative Medicine. 2019. 1–8. 4 indexed citations
10.
Allabi, Aurel Constant, et al.. (2017). Microbiological quality assessment of aqueous herbal teas sold in Cotonou, Benin. International Journal of Herbal Medicine. 5(3). 121–126. 1 indexed citations
11.
Allabi, Aurel Constant, et al.. (2017). Evaluation of the knowledge and attitude of pharmacists about the national malaria control policy in southern Benin. Malaria Journal. 16(1). 231–231. 11 indexed citations
12.
Allabi, Aurel Constant. (2014). A Situational Analysis of Pharmacovigilance System in Republic of Benin. Journal of Pharmacovigilance. 2(4). 6 indexed citations
13.
Allabi, Aurel Constant, et al.. (2012). Effectiveness of the medicinal plant R019 in the treatment of HIV infection: an observational study. Journal of Applied Pharmaceutical Science. 2(2). 59–65. 4 indexed citations
14.
Ghobadi, Cyrus, Trevor N. Johnson, Mohsen Aarabi, et al.. (2011). Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients. Clinical Pharmacokinetics. 50(12). 809–822. 73 indexed citations
15.
Allabi, Aurel Constant, Yves Horsmans, Jean‐Claude Alvarez, et al.. (2011). Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects. European Journal of Drug Metabolism and Pharmacokinetics. 37(2). 125–132. 4 indexed citations
16.
Allabi, Aurel Constant, et al.. (2010). The use of medicinal plants in self-care in the Agonlin region of Benin. Journal of Ethnopharmacology. 133(1). 234–243. 78 indexed citations
17.
Allabi, Aurel Constant, Jean‐Luc Gala, & Yves Horsmans. (2005). CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population. Pharmacogenetics and Genomics. 15(11). 779–786. 81 indexed citations
18.
Allabi, Aurel Constant, et al.. (2005). Single nucleotide polymorphisms of ABCB1 (MDR1) gene and distinct haplotype profile in a West Black African population. European Journal of Clinical Pharmacology. 61(2). 97–102. 42 indexed citations
19.
Allabi, Aurel Constant. (2004). Functional impact of CYP2C9*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans*1. Clinical Pharmacology & Therapeutics. 76(2). 113–118. 66 indexed citations
20.
Allabi, Aurel Constant, Jean‐Luc Gala, Jean‐Pierre Desager, Michel Heusterspreute, & Yves Horsmans. (2003). Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations. British Journal of Clinical Pharmacology. 56(6). 653–657. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Jande Breakdown of academic impact, for papers by Michael Deters Breakdown of academic impact, for papers by C. H. Shashindran Breakdown of academic impact, for papers by Feng Yu Breakdown of academic impact, for papers by James B. Mangold Breakdown of academic impact, for papers by Hidetoshi Furuie Breakdown of academic impact, for papers by Dorothee Frank Breakdown of academic impact, for papers by A N Nafziger Breakdown of academic impact, for papers by Debra S. Israel Breakdown of academic impact, for papers by Y Clément
Rankless by CCL
2026